Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership288,264 shares
Latest Disclosed Value $ 1,031,963
Dimensional Fund Advisors Lp reports 14.92% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 288,264 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $811,463 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 338,830 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -14.92% during the quarter. The current value of the position is $703,364 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 288,264 -50,566 -14.92 1,032 -13.29 0.0000
2026-02-12 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 338,830 -216,993 -39.04 1,189 -34.38 0.0002
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 555,823 -4,127 -0.74 1,812 32.07 0.0004
2025-08-12 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 559,950 -17,538 -3.04 1,372 -64.39 0.0003
2025-05-13 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 577,488 -183,453 -24.11 3,853 -59.71 0.0010
2025-02-13 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 760,941 -151,664 -16.62 9,565 -43.26 0.0023
2024-11-07 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 912,605 -33,570 -3.55 16,856 -17.26 0.0041
2024-08-09 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 946,175 -83,613 -8.12 20,371 -26.57 0.0053
2024-05-10 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,029,788 -18,153 -1.73 27,742 -11.67 0.0075
2024-02-07 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,047,941 -288,731 -21.60 31,409 14.67 0.0092
2023-11-09 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,336,672 -2,487 -0.19 27,389 2.93 0.0090
2023-08-09 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,339,159 66,665 5.24 26,610 22.08 0.0085
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,272,494 144,133 12.77 21,796 98,972.73 0.0073
2023-02-09 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,128,361 244,792 27.70 22 -99.84 0.0065
2022-11-10 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 883,569 446,574 102.19 14,099 134.51 0.0054
2022-08-12 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 436,995 21,730 5.23 6,012 -8.72 0.0022
2022-05-13 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 415,265 28,826 7.46 6,586 -21.95 0.0020
2022-02-09 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 386,439 11,983 3.20 8,438 -24.61 0.0026
2021-11-12 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 374,456 -122,854 -24.70 11,193 -49.18 0.0036
2021-08-12 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 497,310 189,020 61.31 22,024 61.03 0.0070
2021-05-14 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 308,290 -27,716 -8.25 13,677 -25.79 0.0045
2021-03-08 2020-12-31 13F/A-2 ROCKET PHARMACEUTICALS COM 77313F106 336,006 -7,006 -2.04 18,429 135.03 0.0067
2021-02-11 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 336,006 -7,006 18,429 6,655.5752
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 343,012 3,104 0.91 7,841 10.20 0.0033
2020-08-13 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 339,908 64,422 23.38 7,115 85.14 0.0031
2020-05-14 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 275,486 19,578 7.65 3,843 -34.03 0.0020
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 255,908 115,850 82.72 5,825 256.92 0.0021
2019-11-12 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 140,058 119,334 575.83 1,632 424.76 0.0006
2019-08-13 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 20,724 8,612 71.10 311 46.70 0.0001
2019-08-12 2019-03-31 13F/A-2 ROCKET PHARMACEUTICALS COM 77313F106 12,112 0 0.00 212 18.44 0.0001
2019-05-10 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 12,112 0 212
2019-02-26 2018-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 12,112 12,112 0.00 179 0.00 0.0001
2019-02-13 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 12,112 179
2017-11-13 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -35,881 -100.00 0 -100.00
2017-08-11 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 35,881 8,369 30.42 68 23.64 0.0000
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 27,512 -3,086 -10.09 55 -70.59 0.0000
2017-02-09 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 30,598 0 0.00 187 -35.52 0.0001
2016-11-10 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 30,598 30,598 290 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.